Stimuli-Responsive "Smart" Release
In 2026, we use "responsive" materials that only release the drug when they sense a specific change in the body.
pH-Responsive Systems: These devices or capsules wait until they reach a specific environment (like the low-acid environment of the intestine or the high-acid environment of a tumor) before opening.
Glucose-Sensing Insulin: Smart insulin delivery systems in 2026 can sense high blood sugar and automatically trigger the release of insulin, acting like an "artificial pancreas."
Enzyme-Triggered Release: Some cancer drugs are wrapped in a protective coating that only "unlocks" when it encounters an enzyme produced specifically by cancer cells, preventing damage to healthy tissue.
1 View